Antiphospholipid Syndrome iBook

FollowFollowFollowFollowFollow  Contact  Events i Newsletter   home DONATE Donate Now 2023 Giving Tree Fundraisers Our Mission Our Mission Medical Advisory Board Founders of the APSFA Testimonials APSFA Photo Album APSFA in the Media What is APS?...

Rare Diseases Clinical Research Network

The Rare Diseases Clinical Research Network was created to facilitate collaboration among experts in many different types of rare diseases. Our goal is to contribute to the research and treatment of rare diseases by working together to identify biomarkers for disease...

Clinical Study: PROMISSE

NOW RECRUITING Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS) (PROMISSE) The PROMISSE Study is an observational study of 700 pregnant patients, enrolled at nine major clinical centers. The purpose of the study...

Clinical Study: Genetic Risk Factors Associated With APS

NOW RECRUITING Genetic Risk Factors Associated With Antiphospholipid Syndrome (APS) Antiphospholipid syndrome (APS) is characterized by the presence of antiphospholipid antibodies, which are proteins in the blood that interfere with the body’s ability to perform...

APS ACTION

The primary mission of APS ACTION is to prevent, treat, and cure antiphospholipid antibody (aPL) associated clinical manifestations through high-quality, multicenter, and multidisciplinary clinical research. Their secondary mission is to refine and advance the...